137578-39-3

Upstream product

• 99059-06-0 2,3-dihydro-3-(hydroxymethyl)-1,4-benzodioxin-5-carboxaldehyde 
• 86734-60-3 2-(benzyloxy)-3-hydroxybenzaldehyde 
• 137578-50-8 2,3-dihydro-2-<<(p-tolylsulfonyl)oxy>methyl>-7H-1,4-dioxino<2,3-e>indole-8-carboxylic acid methyl ester 
• 137578-48-4 2,3-dihydroxy-2-<(tert-butyldimethylsiloxy)methyl>-7H-1,4-dioxino<2,3-e>indole-8-carboxylic acid methyl ester 
• 137578-49-5 2,3-dihydroxy-2-(hydroxymethyl)-7H-1,4-dioxino<2,3-e>indole-8-carboxylic acid methyl ester 
• 137578-44-0 3-(oxiranylmethoxy)-2-(phenylmethoxy)benzaldehyde 
• 137578-46-2 3-<(tert-butyldimethylsiloxy)methyl>-2,3-dihydro-1,4-benzodioxin-5-carboxaldehyde 
• 137578-23-5 2-(4-Oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-8-ylmethyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole-8-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Novel indolodioxanes with antihypertensive effects: Potent ligands for the 5-HT(1A) receptor

The synthesis and biological evaluation of a new family of tricyclic indolodioxanes is described. These compounds all contain the 2,3-dihydro-7H- 1,4-dioxino[2,3-e]indole nucleus and bear substituents at the 2 and/or 8 positions. Thirteen members of this